Susquehanna International Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.25M | Sell |
161,136
-6,061
| -4% | -$84.8K | ﹤0.01% | 2149 |
|
2025
Q1 | $2.27M | Buy |
167,197
+95,957
| +135% | +$1.3M | ﹤0.01% | 2119 |
|
2024
Q4 | $1.45M | Buy |
71,240
+21,070
| +42% | +$429K | ﹤0.01% | 2420 |
|
2024
Q3 | $1.46M | Sell |
50,170
-10,228
| -17% | -$298K | ﹤0.01% | 2230 |
|
2024
Q2 | $1.4M | Sell |
60,398
-44,242
| -42% | -$1.03M | ﹤0.01% | 2147 |
|
2024
Q1 | $2.15M | Buy |
104,640
+43,726
| +72% | +$897K | ﹤0.01% | 1734 |
|
2023
Q4 | $1.31M | Sell |
60,914
-32,889
| -35% | -$706K | ﹤0.01% | 2480 |
|
2023
Q3 | $1.94M | Sell |
93,803
-23,789
| -20% | -$491K | ﹤0.01% | 1864 |
|
2023
Q2 | $3.47M | Sell |
117,592
-222,972
| -65% | -$6.58M | ﹤0.01% | 1384 |
|
2023
Q1 | $7.85M | Buy |
340,564
+317,311
| +1,365% | +$7.31M | ﹤0.01% | 856 |
|
2022
Q4 | $647K | Sell |
23,253
-73,374
| -76% | -$2.04M | ﹤0.01% | 2860 |
|
2022
Q3 | $2.97M | Buy |
96,627
+86,101
| +818% | +$2.64M | ﹤0.01% | 1280 |
|
2022
Q2 | $310K | Sell |
10,526
-75,192
| -88% | -$2.21M | ﹤0.01% | 3953 |
|
2022
Q1 | $2.76M | Sell |
85,718
-33,177
| -28% | -$1.07M | ﹤0.01% | 1679 |
|
2021
Q4 | $5.3M | Buy |
118,895
+66,798
| +128% | +$2.98M | ﹤0.01% | 1140 |
|
2021
Q3 | $2.63M | Buy |
52,097
+32,872
| +171% | +$1.66M | ﹤0.01% | 1688 |
|
2021
Q2 | $1.51M | Buy |
19,225
+4,101
| +27% | +$322K | ﹤0.01% | 2410 |
|
2021
Q1 | $864K | Sell |
15,124
-9,996
| -40% | -$571K | ﹤0.01% | 3169 |
|
2020
Q4 | $2.1M | Buy |
25,120
+8,737
| +53% | +$732K | ﹤0.01% | 1684 |
|
2020
Q3 | $587K | Buy |
16,383
+3,700
| +29% | +$133K | ﹤0.01% | 2851 |
|
2020
Q2 | $307K | Sell |
12,683
-27,441
| -68% | -$664K | ﹤0.01% | 3372 |
|
2020
Q1 | $703K | Buy |
+40,124
| New | +$703K | ﹤0.01% | 2461 |
|
2019
Q4 | – | Sell |
-59,852
| Closed | -$917K | – | 4162 |
|
2019
Q3 | $917K | Buy |
59,852
+21,927
| +58% | +$336K | ﹤0.01% | 2120 |
|
2019
Q2 | $787K | Buy |
+37,925
| New | +$787K | ﹤0.01% | 2381 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 3635 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 3853 |
|